---
title: 4Q 2018 Results and preliminary annual report
description: Moss, 28 February 2019. Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results.
---

Moss, 28 February 2019

 

Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results. The highlights include:

 

- Record sales revenues of MNOK 11.1 for the quarter
- 42 % growth in underlying sales revenue compared to 4Q17, 43 % year to date
- All time high sales results achieved with fCAL® turbo

 

 

Please find the report here:  [GDAS 2018 4Q Interim report[2594]](https://www.gentian.com/hubfs/GDAS-2018-4Q-Interim-report2594.pdf) or on [Oslo Børs NewsWeb](https://newsweb.oslobors.no/message/470795).

 

**For further information, please contact:**

 

Hilja Ibert   
CEO, Gentian Diagnostics   
E-mail: [hilja.ibert@gentian.no](mailto:hilja.ibert@gentian.no)   
Cell Phone: +47 919 05 242

 

Njaal Kind   
CFO, Gentian Diagnostics   
E-mail: [njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)   
Cell Phone. +47 919 06 525

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/4q-2018-results-preliminary-annual-report#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/4q-2018-results-preliminary-annual-report#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/4q-2018-results-preliminary-annual-report#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)